The BC Bud Corp. (ENTH.H) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CAD 7 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.96

Return on Equity

-110.36%

Price to Book

4.85

Revenue and Profits:

Net Sales:

(Quarterly Results - May 2025)

Net Profit:

0 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-37.5%

6 Months

-37.5%

1 Year

-66.67%

2 Years

-28.57%

3 Years

-37.5%

4 Years

-84.85%

5 Years

0.0%

The BC Bud Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

2.29%

EBIT Growth (5y)

-183.26%

EBIT to Interest (avg)

-0.86

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.90

Sales to Capital Employed (avg)

0.47

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

4.85

EV to EBIT

-2.90

EV to EBITDA

-2.91

EV to Capital Employed

5.39

EV to Sales

5.39

PEG Ratio

Dividend Yield

ROCE (Latest)

-186.08%

ROE (Latest)

-110.36%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

Bullish

Bearish

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - May'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended May 2025 is 0.00% vs -100.00% in May 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended May 2025 is 0.00% vs 100.00% in May 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "May'25",
        "May'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.30",
          "val2": "-0.30",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.30",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "-40,768.60%",
          "chgp": "4,076.86%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Feb'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Feb 2025 is 0.00% vs -66.67% in Feb 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Feb 2025 is -58.33% vs 14.29% in Feb 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Feb'25",
        "Feb'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.80",
          "val2": "-1.20",
          "chgp": "-50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.90",
          "val2": "-1.20",
          "chgp": "-58.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-12,566.10%",
          "val2": "-19,666.80%",
          "chgp": "710.07%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - May'25 - YoY

May'25

May'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-0.30

Interest

0.00

Exceptional Items

0.10

0.00

Consolidate Net Profit

-0.30

0.00

Operating Profit Margin (Excl OI)

0.00%

-40,768.60%

4,076.86%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended May 2025 is 0.00% vs -100.00% in May 2024

Consolidated Net Profit

YoY Growth in quarter ended May 2025 is 0.00% vs 100.00% in May 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Feb'25

Feb'25

Feb'24

Change(%)

Net Sales

0.10

Operating Profit (PBDIT) excl Other Income

-1.80

-1.20

-50.00%

Interest

0.00

Exceptional Items

-0.10

0.00

Consolidate Net Profit

-1.90

-1.20

-58.33%

Operating Profit Margin (Excl OI)

-12,566.10%

-19,666.80%

710.07%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Feb 2025 is 0.00% vs -66.67% in Feb 2024

Consolidated Net Profit

YoY Growth in year ended Feb 2025 is -58.33% vs 14.29% in Feb 2024

All Annual Results

Company CV

About The BC Bud Corp.

The BC Bud Corp.

Pharmaceuticals & Biotechnology

Entheos Capital Corp. is a Canada-based company. The Company offers a range of financial and communications services to companies in various industry sectors. The Company provides business advisory services in connection with venture capital markets, investor relations, initial public offerings and secondary financings, mergers and acquisitions, public market administration, as well as media and marketing advice. The Company offer Business Advisory and Capital Markets services to a range of growth companies. The Company's Business Advisory platform offers a range of products and services designed for clients' exposure and visibility within a network of Investment Advisors in independent and bank-owned investment dealers.

Company Coordinates

Company Details

Suite 2080-777 Hornby Street , VANCOUVER BC : V6Z 1S4

Tel: 1 778 6560377

http://waterfrontcapitalcorp.com/

Registrar Details